U.S. Markets close in 3 hrs 29 mins

The Case for a Biogen Acquisition — and 3 Potential Targets

Teresa Rivas

Biogen stock has been through the wringer in 2019, and some think an acquisition could get it back on track. Here are several potential takeover targets.